相关实验视频

Updated: Jan 14, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

质瘤中的T细胞免疫和对免疫治疗的潜在影响:系统性审查

Rosa Luning¹, Pim J French¹, Wouter J F Vanbilloen^1,2

¹Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

|October 17, 2025

概括

在质瘤中,T细胞稀缺且功能惰性,阻碍了免疫治疗的成功. 了解它们的低密度和耗尽的表型是开发有效的质瘤免疫疗法的关键.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

基于T细胞的免疫疗法在质瘤治疗中表现出有限的疗效.
在质瘤瘤微环境 (TME) 中研究T细胞特征对于改善免疫治疗结果至关重要.

研究的目的:

评估IDH突变和IDH野生型质瘤中的T细胞丰度,空间分布和表型.
了解T细胞特征与质瘤免疫疗法耐药性之间的关系.

主要方法:

在多个数据库中进行系统的文献搜索,直到2025年5月.
选择和分析85项关于人类质瘤T细胞免疫力的研究.
收集关于瘤亚型,等级,T细胞丰度,空间分布,表型和预后意义的数据.

主要成果:

在质瘤TME中存在但稀少的T细胞,特别是在IDH突变质瘤中,随着等级和复发而增加.
透的T细胞表现出耗尽的表型 (例如PD-1+,CTLA-4+) 并聚集在血管周围.
这种耗尽的表型与减少的抗瘤细胞毒性相关,并富含缺氧瘤核.

结论:

质瘤T细胞通常稀缺,完全分化,功能性抑制.
强化缺陷的T细胞反应对于成功的质瘤免疫疗法至关重要.
未来的研究需要针对个性化免疫疗法策略进行功能和空间免疫分析.

关键词:

质瘤是一种质瘤.在T细胞,T细胞.在此之前,TME的免疫疗法免疫疗法现象型现象型是一种现象型.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.